S
Shukra Pharmaceuticals
31.79
BSE
S
Shukra Pharmaceuticals
31.79
BSE
SHUKRAPHAR Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,392
PE Ratio
63.60
PB Ratio
15.49
Dividend Yield
0.03%
ROE
15.24%
ROCE
20.05%
Book Value (₹)
2.05
Face Value (₹)
1.00
Analyse SHUKRAPHAR with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% |
| Domestic Institutional Investors (DII) | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 9.29% | 28.69% | 9.20% | 9.43% | 9.37% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
SHUKRAPHAR Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524632
NSE Scrip Name
SHUKRAPHAR
ISIN
INE551C01044



